1,050
Participants
Start Date
March 8, 2021
Primary Completion Date
April 8, 2021
Study Completion Date
September 8, 2021
batch 1 of Ad5-nCoV
The vaccine is a replication defective Ad5 vectored vaccine expressing the full-length spike glycoprotein of SARS-CoV-2 produced by CanSino, lot NCOV202101001. It contains 5×10\^10 viral particles per 0.5 mL in a vial.
batch 2 of Ad5-nCoV
The vaccine is a replication defective Ad5 vectored vaccine expressing the full-length spike glycoprotein of SARS-CoV-2 produced by CanSino, lot NCOV202101002. It contains 5×10\^10 viral particles per 0.5 mL in a vial.
batch 3 of Ad5-nCoV
The vaccine is a replication defective Ad5 vectored vaccine expressing the full-length spike glycoprotein of SARS-CoV-2 produced by CanSino, lot NCOV202102003. It contains 5×10\^10 viral particles per 0.5 mL in a vial.
Guanyun Center for Disease Control and Prevention, Lianyungang
Jiangsu Province Centers for Disease Control and Prevention
NETWORK